Antibiotic resistance is the most important factor leading to the failure of eradication regimens. This review focuses on the prevalence of Helicobacter pylori primary and secondary resistance to clarithromycin, metronidazole, amoxicillin, levofloxacin, tetracycline, and multidrug in Vietnam. We searched the PubMed, EMBASE, Vietnamese National Knowledge Infrastructure, and Vietnamese Biomedical databases from January 2000 to December 2016. The search terms included the following: H. pylori infection, antibiotic (including clarithromycin, metronidazole, amoxicillin, levofloxacin, tetracycline, and multidrug) resistance in Vietnam. The data were summarized in an extraction table and analyzed manually. Finally, Excel 2007 software was used to create charts. Ten studies (three studies in English and seven in Vietnamese) were included in this review. A total of 308, 412, 523, 408, 399, and 268 H. pylori strains were included in this review to evaluate the prevalence of H. pylori primary resistance to amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and multidrug resistance, respectively. Overall, the primary resistance rates of amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and multidrug resistance were 15.0%, 34.1%, 69.4%, 27.9%, 17.9% and 48.8%, respectively. Secondary resistance rates of amoxicillin, clarithromycin, metronidazole, levofloxacin, tetracycline, and multidrug resistance were 9.5%, 74.9%, 61.5%, 45.7%, 23.5% and 62.3%, respectively. In Vietnam, primary and secondary resistance to H. pylori is increasing over time and affects the effectiveness of H. pylori eradication. (Gut Liver 2019;13:483-497 ) 
INTRODUCTION
In 1983, Marshall and Warren 1 discovered Helicobacter pylori-a gram-negative bacillus that infects the human stomach mucosa. Further studies confirmed that H. pylori is the main cause of chronic gastritis, peptic ulcer disease, gastric marginal zone/mucosa-associated lymphoid tissue (MALT) lymphoma and gastric carcinoma. [2] [3] [4] [5] [6] [7] Recently, it has been suggested that H.
pylori may be associated with extraintestinal diseases, including immune thrombocytopenic purpura, refractory iron deficiency anemia and vitamin B 12 deficiency. 8, 9 Globally H. pylori has been classified as a class I carcinogen and the major cause of gastric cancer. 10 In Vietnam, frequency of H. pylori infection is rather popular and similar to that in the other developing countries. A largescale study showed that frequency of H. pylori infection made up over 70% in adults and lightly reduced in children. [11] [12] [13] [14] An investigation study in a hospital indicated that frequency of H. pylori infection was 59.9% to 69.9% for chronic gastritis; 77.8% for gastric ulcer; 85% to 95% for duodenal ulcer and 85.3% to 93.6% for gastroduodenal ulcer. [14] [15] [16] Generally, H. pylori eradication is indicated in cases of peptic ulcer including active, non-active and complicated, gastric MALT lymphoma, and to some extent, chronic gastritis and functional dyspepsia. Eradication of H. pylori not only heals peptic ulcers, but also prevents their recurrence and reduces the risk of development of gastric cancer. [17] [18] [19] [20] [21] In addition, diseases related to H. pylori such as MALT lymphoma, gastric atrophy and intestinal dysplasia are also recoverable after antibiotic treatment. 22, 23 Triple therapy regimens including one proton pump inhibitor (PPI) and two antimicrobial agents such as amoxicillin (A), clarithromycin (C), metronidazole (M), levofloxacin (L), and tetracycline (Te) have been widely used to eradicate this bacterium. Although rate of successful eradication treatment depends on many factors such as smoking and patients' compliance, antibiotic resistance is an important factor reducing treatment efficiency. 24, 25 Rate of the antibiotic resistance is higher in the developing countries than in the developed countries. 26, 27 In addition, the rate of antibiotic resistance often correlates with the amount of antibiotics consumed in the population. 3, [28] [29] [30] In
Vietnam, based on International Consensus, regimens of using two antibiotic drugs: clarithromycin and amoxicillin, or clarithromycin and metronidazole, are standard regimen to eradicate H. pylori. 20, 31, 32 In Vietnam, in early 1990s, rate of H. pylori eradication exceeded 90%. However, recent statistics indicate that H. pylori eradication rate has decreased to 60%-70%. The most important cause for the reduced success of standard triple therapy is the increasing rate of H. pylori clarithromycin/metronidazole/levofloxacin resistance. [33] [34] [35] In this review, we provide the following information: (1) 
Prevalence and risk factors of H. pylori infection in Vietnam
There is a difference in rate of H. pylori infection among the Asian countries and even in a country. 36 The rate of H. pylori infection depends on socio-economic and environmental conditions. Frequency of H. pylori infection in the developing countries is often higher than that in the developed countries.
In developing countries such as India and Saudi Arabia and African countries, the infection rate is high and approximately 80% of the population infected with H. pylori by 20 years old. 37 In contrast, the infection rate is reported to be as low as 10% to 20% in developed countries, and the infection rate increases at a rate of approximately 1% per year. 38 In Japan, the rate of H. pylori infection in children under the age of 10 is very low (approximately 5%) and the rate of H. pylori infection gradually increases by ages. 
Prevalence of H. pylori infection in patients with gastric cancer
Globally H. pylori has been classified as a class I carcinogen and the major cause of gastric cancer. 10 Many studies focused on the relation between the gastric cancer and the rate of H. pylori infection, virulence factors of H. pylori (cagA, vacA, etc. 
EFFICIENCY OF H. PYLORI ERADICATION REGIMEN IN VIETNAM 1. Efficiency of H. pylori eradication by first-line therapy
Triple therapy has been early and widely used in three regions of Vietnam (North, Central, and South Vietnam). In the decade: 1990 to 2000, when there had not been the antibiotic resistance, the triple therapy had been widely applied in clinical treatment in Vietnam. The triple therapy includes a proton pump inhibitors (PPI) and two antibiotics. PPIs having been used in Vietnam consist of omeprazole, lansoprazole, pantoprazole, rabeprazole and esomeprazole. There are three antibiotics commonly used in legacy triple therapies including clarithromycin (CLR), amoxicillin (AMX), metronidazole (MNZ).
The appropriate regimen is to achieve the following criteria:
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(1) Efficacy of eradication of H. pylori should be >90% as per protocol (PP) and >80% according to the intent to treat (ITT); (2) Low side effects, patients' easy to accept and reasonable prices, etc.
Underlying methods in the published papers and analyzed data from different hospitals in Vietnam were selected for this review. All most patients were undergone upper gastrointestinal endoscopy and tested for H. pylori (before and after treatment for 30 days).
Diagnosis of H. pylori infection by histopathology: two gastric biopsy specimens, one from the antrum and one from the corpus, were fixed in 10% formalin in separate containers and were sent to the pathology laboratory. Samples were embedded in paraffin wax, cut at 5 μm thickness, and stained with modified Giemsa and hematoxylin and eosin. Histological evaluation of the samples for H. pylori was performed according to the modified Sydney system. Rapid urease test (RUT) is the most useful invasive test for the diagnosis of H. pylori infection because it is inexpensive, rapid, easy to perform and shows high sensitivity. Several commercial urease tests including gel-based tests (CLO test, HpFast), paper-based tests (PyloriTek, ProntoDry) and liquid-based tests (UFT300, EndoscHp) are available now.
Recently, we also use the breath test to detect H. pylori. However, we only use the 14 C-urease breath test ( 14 C-UBT). 55 Before 2010, techniques for the detection of H. pylori infection as UBT, cultures are not applied much (due to lack of equipment and lack of funds). Thus, most studies use RUT and / or histopathology to evaluate the efficacy of H. pylori eradication. Two studies have used RUT to detect H. pylori infection. 56, 57 One study 55 used a 14 C-UBT. 72 found that the efficacy of eradication of H.
pylori by EBMT was 89.3%. However, in this study, the number of patients with moderate, severe and severe adverse events was 19.88%, 0.60% and 1.81%, respectively. Other two studies using the triple therapy with levofloxacin had the rate of H. pylori eradication of over 80%. 73, 74 These results indicate that the therapeutic effect of levofloxacin in the rescue regimen is low and is associated with H. pylori resistance. These results show that primary and secondary antibiotic resistance of H. pylori in Vietnam has increased over time, especially for clarithromycin and metronidazole. However, limitations in our study that the number of studies is small, intermittent and use classic methods (RUT, endoscopy and histology) to detect H. pylori. Therefore, there should be many more studies, in many different centers and longer duration. There are many factors that affect efficiency of H. pylori eradication therapies such as patient's compliance, doses, quality of drugs, combined diseases, etc. Among those factors, the emergence of antibiotic-resistant H. pylori strains have been implicated as highest risk of treatment failure. The antibiotic resistance to H. pylori is divided into two types: primary antibiotic resistance and secondary antibiotic resistance.
There are two methods for detecting H. pylori resistance, including resistance to phenotypic resistance and genotype resistance. Phenotypic methods are applied in Vietnam since 2000. The methods include agar dilution method, disk dilution method and Epsilometer test. Method of detecting H. pylori genotype resistance has only been applied in recent years. Table 3 presents the rate of primary antibiotic resistance to H. 83 Recently, Kuo et al. 84 have reviewed the system and metaanalysis of primary antibiotic resistance to H. pylori and the efficacy of first-line regimens in the Asia-Pacific region. The overall mean prevalence of primary H. pylori resistance were 17% (95% CI, 15% to 18%) for clarithromycin, 44% (95% CI, 39% to 48%) for metronidazole, 18% (95% CI, 15% to 22%) for levofloxacin, 3% (95% CI, 2% to 5%) for amoxicillin, and 4% (95% CI, 2% to 5%) for tetracycline. Prevalence of resistance to clarithromycin and levofloxacin rose significantly over time during the period investigated, whereas resistance to other antibiotics remained stable. In Vietnam, the prevalence of primary resistance of H. pylori with clarithromycin and metronidazole was 34.0% and 72.0%, respectively, and it was ranked second (after Pakistan). 85 In Korea, Lee et al. 85 In Vietnam, clarithromycin is the first line antibiotic selected in the triple therapy for H. pylori eradication treatment. Table 3 shows the proportion of primary resistance clarithromycin according to various studies. 16, [33] [34] [35] [75] [76] [77] [78] [79] [80] Rate of primary resistance to clarithromycin ranged from 21.4% to 85.5%. Therefore, clarithromycin resistance has increased, especially in the studies in the South Vietnam. 35 In the North Vietnam, clarithromycin resistance had trended to further increase from 18.5% in 2013 to 42.1% in 2015 (Table 5) . 16 The patients with the primary clarithromycin resistance will 
Primary and secondary amoxicillin resistance of H. pylori in Vietnam
Resistance to amoxicillin has been shown to be negligible (0 to <2%) in European countries, such as Germany and the Netherlands. 91 In Asia, mean overall prevalence of resistance to amoxicillin was 3% (95% CI, 21% to 34%). 84 In Vietnam, amoxicillin is used in the triple therapy or the quadruple therapy for H. pylori eradication. The rate of the primary amoxicillin resistance varies in different times and studies: from 0% to 43.6% (Table 3) . 33, 77, 80 The rate of the primary amoxicillin resistance in the North Vietnam has trended to further increase (18.1% to 43.6%) 76, [78] [79] [80] than in the South Vietnam (0% to 10.4%) (Table 3) . 16, [33] [34] [35] 77 Vinh 76 found that the rate of the secondary resistance of amoxicillin was 36.8%. Minh and Hoang 81 found that the rate of the secondary amoxicillin resistance after 1, 2 and 3 treatments was 13.6%, 16.7%, and 0% (Table 4 ). Secondary resistance rates of amoxicillin in Southern Vietnam are lower than in the North Vietnam. Because of amoxicillin resistance rate is not high, so amoxicillin still used for H. pylori eradication in Vietnam.
Primary and secondary metronidazole resistance of H. pylori in Vietnam
Metronidazole in order to eradicate this bacterium, has been widely used in combination therapies such as metronidazolebased triple therapy, concomitant therapy and bismuth-containing quadruple therapy. Metronidazole resistance is the most common antibiotic resistance in H. pylori and overall metronidazole resistance found in 47.22% in descending order in Africa 75.02%, South America 52.85%, Asia 46.57%, Europe 31.19%, to 30.5% in North America. 88 In Asia, mean overall prevalence of resistance to metronidazole was 44% (95% CI, 39% to 48%) ranging from 10% in Japan to 84% in Bangladesh and 88% in Nepan. 84 In the 1990s, metronidazole was early used in H. pylori eradication regimen and used in the North Vietnam more than in the South Vietnam. Primary resistance rate of metronidazole from: 37.8% 35 to 95.5%. 77 The rate of the primary metronidazole resistance in the North Vietnam increased (38.1% to 95.5%) 75, 79 higher than that in the South Vietnam (37.8% to 50.8%) (Table  3) . 35, 77 The rate of the primary metronidazole resistance has increased by time. In Hanoi, the rate of the primary metronidazole resistance increased from 70.3% in 2013 to 89.5% in 2015 (Table  5 ). In Ho Chi Minh City, the rate of the primary metronidazole resistance increased from 69.3% in 2013 to 81.4% in 2015 (Table  5) . 16, 33 Metronidazole is used frequently to treat not only H. pylori infection but also other infections such as intestinal parasites, periodontal, and gynecological diseases, which are common in developing countries, including Vietnam. 26 Because the drug has many side-effects, causing tiredness for the patients and high rate of resistance, metronidazole has not been used in the regimen of H. pylori eradication in Vietnam. 67 
Primary and secondary tetracycline resistance of H. pylori in Vietnam
In the world, the rate of tetracycline resistance is low, especially in the developed countries. 90 In Asia and Africa, tetracycline and bismuth are used more than in Europe and the America. 84, 88 The total rate of tetracycline resistance did not vary in South America and North America (the resistance was absent), whilst it was relatively high in Africa (50%). In Asia, the resistance was absent in Thailand, and very low in China (0.6%) and South Korea (0.01%). In contrast, increased values were found in India (53.8%), and Iran (11.7%). The prevalence of tetracycline resistance stays very low (less than 7.4%) in almost parts of the world except for Africa. 88 The comparison of data showed that tetracycline resistance was decreasing in the world, 26.85% in 2009 to 6.11% in 2014. 88 In Vietnam (see Table 5 ), the primary tetracycline resistance ranges 5.8% to 21.4% (Table 3 ). Minh and Hoang 81 found that the rate of the secondary tetracycline resistance after 1, 2, and 3 treatments ( 
Primary and secondary levofloxacin resistance of H. pylori in Vietnam
Many studies have examined levofloxacin-PPI as a first-line therapy for eradication of H. pylori infection. 92, 93 However, the eradication rates achieved with first-line levofloxacin-based treatments are not uniform. Some reports show the improved efficacy with levofloxacin-based regimens in comparison to standard first-line therapy, whereas others have found equivalent or poorer responses. 94, 95 The European recommendation only uses levofloxacin in the rescue regimen, when the results of antibiotic therapy are available. 20 When first-line therapy fails, the Maastricht IV Consensus Report recommends that bismuthcontaining quadruple therapy can be a choice for second-line therapy. 8 Many studies have investigated levofloxacin based regimens as second-line treatments, including meta analyses. 96 Generally, resistance to levofloxacin is low (<19%) worldwide. The rate of the primary levofloxacin resistance varies in the world's regions and increases in Asian (25.28%) and South America (21.23%) higher than that in Africa and Europe (<15%). In Asia, the rate of levofloxacin resistance also varies in different countries: Japan (57%), Korea (24.55%), Iran (5.3%), and Malaysia (2.6%). 88 In Vietnam, a majority of the studies focused in the South Vietnam 16, [33] [34] [35] and their results indicated that the rate of the primary levofloxacin resistance ranged from 18.4% to 35.6% (Table  3 ). The rate of the primary levofloxacin resistance increased from 18.3% in 2013 to 41.2% in 2015 in Ho Chi Minh City (Table  5) . 16, 33 The rates of the secondary levofloxacin resistance after 1, 2 and 3 treatments were 25.7%, 23.3%, and 33.3% respectively (Table 4) . 81 Phan et al. 34 found that the rates of the primary and secondary levofloxacin resistance were very high and 35.6% and 63.2%, respectively (p<0.05). Other fluoroquinolones such as nalidixic acid, ciprofloxacin and ofloxacin, which are commonly used in Vietnam, may lead to cross resistance with levofloxacin. Because the rate of levofloxacin resistance increased, so levofloxacin is not used much in H. pylori eradication in Vietnam.
Multidrug resistance patterns of H. pylori in Vietnam
Multidrug resistance has recently appeared as a serious challenge in the fight against infections in over the world. H. pylori strains harboring triple or quadruple resistance can hinder the choice and success of the eradication regimen. Binh et al. showed that 33% (34 strains) of the isolates were the resistant to at least two antibiotics. Resistance to clarithromycin and metronidazole was most commonly observed (24.3%), and this may be the main reason for failure of treatment in Vietnam. Fig. 3 presents the multidrug resistance of H. pylori in Vietnam.
CAUSES OF ANTIBIOTIC RESISTANCE IN VIETNAM 1. Contributory factors
The contributory factors to treatment failure are multidimensional and complex. Host genetic factors, H. pylori virulent factors, antibiotic-resistant H. pylori strains, smoking habits, compliance to therapy and duration of therapy affect totally treatment outcome. In Vietnam, Dung et al. 16 found that some causes as follows: wide use of antibiotics, incorrect dosage, quality of antibiotic, noncompliance of treatment protocol, bad habits (alcohol and tobacco consumption), mutation of H. pylori.
In fact, arbitrary use antibiotics (without a prescription, increase dose arbitrarily) is a common problem in Vietnam and might leading to the development of new antibiotic-resistant H. pylori strains. In addition, bad habits such as alcohol, beer, smoking can also affect the effectiveness of H. pylori eradication.
Several studies have examined the relationship between risk factors and the frequency of primary and secondary resistance of H. pylori. Risk factors should be analyzed include: age, gender, history of previous eradication treatment, smoking, occupation, type of residence, etc. Lee et al. 85 showed that "previous eradication" was an independent risk factor for the development of clarithromycin (p<0.001), azithromycin (p<0.001), levofloxacin (p=0.003) and moxifloxacin (p=0.006) resistance. District: "rural area" was an independent risk factor for the development of azithromycin (p=0.049) resistance. Job: "no occupation" was an independent risk factor for the development of azithromycin (p=0.034) resistance. However, other risk factors (gender, disease, alcohol, smoking, and socioeconomic) was not related to antimicrobial resistance of H. pylori. In Vietnam, there are very few studies on the risk factors associated with H. pylori resistance. Recently, Hue 82 studied the relationship between risk factors and H. pylori resistance. Research results showed that "age ≥30" and "previous eradication" was an independent risk factor for the development of clarithromycin. However, no correlation was found with levofloxacin (Table 6 ).
Gene mutation of H. pylori related to antibiotic resistance
Two techniques applied clinically to define the antibiotic resistance to H. pylori comprise H. pylori culture and resistance regimen. 97 
PERSPECTIVES FROM VIETNAM ASSOCIATION OF GAS-TROENTEROLOGY FOR DIAGNOSIS AND TREATMENT OF H. PYLORI INFECTION
In Vietnam, from 1990 to 2010, triple therapy (PPI + combination of two antibiotics) was used clinically for eradication with H. pylori. However, after more than two decades, the antibiotic resistance to H. pylori has increased by time. Based on International Consensus (Maastricht IV) 8 and based on the increasing resistance of H. pylori to antibiotics in Vietnam, Vietnam Association of Gastroenterology has established a consensus on H. pylori eradication (June 2012 in Ho Chi Minh City). 67 The followings are some main contents related to H. pylori eradication: 67 (1) treatment regimens and duration (Table 7) ;
(2) provide treatment recommendations for areas with increased rates of resistance. Recommendation 25: First-line therapy for H. pylori eradication: Because the rate of antibiotic resistance in the North Vietnam and the Central Vietnam is lower than that in the South Vietnam, the triple therapy (PPI+A+C for 10 to 14 days) is recommended to be applied in this region (grade of recommendation B; agreement: 76%). In the South Vietnam, due to high rate of antibiotic resistance, sequential therapy regime or quadruple therapy (with/without bismuth) for H. pylori eradication (grade of recommendation B; agreement: 83%). However, recent data indicate that primary and secondary resistance of H. pylori to clarithromycin, metronidazole and levofloxacin is increasing. [33] [34] [35] This is of concern and suggests two important principles when prescribing a therapy in Vietnam:
(1) clarithromycin-based or metronidazole-based triple therapy might not be useful as first-line therapies; (2) levofloxacinbased triple therapy should not be used as an alternative treatment. Therefore, first-line strategies such as bismuth-based quadruple or non-bismuth-based quadruple therapy should be recommended for Vietnamese infected patients. In addition, it is necessary to apply techniques such as bacterial culture, antimicrobial susceptibility, gene mutation study of H. pylori is very necessary. The Maastricht V Consensus showed that treatment regimens for areas with clarithromycin resistance >15% and <15%. 69 Based on this, Vietnam Association of Gastroenterology needs to have a new consensus, to improve the effectiveness of H. pylori eradication in the future.
CONCLUSIONS
Vietnam has high rate of H. pylori infection in community as well as in gastric duodenal diseases (chronic gastritis, gastric ulcer, duodenal ulcer, and gastric cancer). In Vietnam, in early 1990s, rate of H. pylori eradication exceeded 90%. But, recent statistics indicated that rate of H. pylori eradication has reduced to 60%-70% and related to antibiotic resistance of H. pylori. The rate of metronidazole, clarithromycin and levofloxacin resistance has been increasing. Application of the recommendations from the International Consensus (Maastricht V/Toronto) is extremely necessary to improve efficiency of H. pylori eradication.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported. 
